Polymer-free biolimus-eluting stents (PF-BES) have been shown superior to bare metal stents in high bleeding risk (HBR) patients treated with 1-month dual antiplatelet therapy (DAPT). However, limited evidence is available on PF-BES in non-HBR patients. We aim to evaluate the safety and efficacy of PF-BES in all-comer patients undergoing percutaneous coronary interventions (PCI).
Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients. the RUDI-FREE study / Sardella, Gennaro; Stefanini, Giulio G; Briguori, Carlo; Tamburino, Corrado; Fabbiocchi, Franco; Rotolo, Francesco; Tomai, Fabrizio; Paggi, Anita; Lombardi, Mario; Gioffrè, Gaetano; Sclafani, Rocco; Rolandi, Andrea; Sciahbasi, Alessandro; Scardaci, Francesco; Signore, Nicola; Calcagno, Simone; Mancone, Massimo; Chiarito, Mauro; Giordano, Arturo. - In: EUROINTERVENTION. - ISSN 1969-6213. - ELETTRONICO. - 14:7(2018), pp. 772-779. [10.4244/EIJ-D-18-00148]
Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients. the RUDI-FREE study
Sardella, Gennaro
;Stefanini, Giulio G;Calcagno, Simone;Mancone, Massimo;Giordano, Arturo
2018
Abstract
Polymer-free biolimus-eluting stents (PF-BES) have been shown superior to bare metal stents in high bleeding risk (HBR) patients treated with 1-month dual antiplatelet therapy (DAPT). However, limited evidence is available on PF-BES in non-HBR patients. We aim to evaluate the safety and efficacy of PF-BES in all-comer patients undergoing percutaneous coronary interventions (PCI).| File | Dimensione | Formato | |
|---|---|---|---|
|
Sardella_Safety_2018.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
797.89 kB
Formato
Adobe PDF
|
797.89 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
